Myriad Genetics is a leading genetic testing and precision medicine company dedicated to advancing health and well-being for all, empowering individuals with vital genetic insights and enabling healthcare providers to better detect, treat and prevent disease. Myriad discovers and commercializes genetic tests that determine the risk of developing disease, assess the risk of disease progression, and guide treatment decisions across medical specialties where critical genetic insights can significantly improve patient care and lower healthcare costs.
Promega provides a broad portfolio of functional bioassays, immunoassays and protein characterization tools to accelerate your biologics drug discovery and development. We offer state-of-the-art reporter and health assays for potency testing, tools for antibody purification and mass spec analysis and a suite of products for simple and fast analyte detection using our Lumit™ luminescence technology. All our products are developed and manufactured under rigorous quality standards and our bioassays are pre-qualified according to ICH guidelines. Learn more to help accelerate your research.
Eurofins Viracor Biopharma
Biopharma is a trusted provider of drug development testing solutions to pharmaceutical companies. We are a leader in bioassay development and testing for infectious diseases, vaccines, immunology, and oncology. For more than 35 years, we have been dedicated to helping clients through specialized clinical trial expertise, and high-quality, accurate results to evaluate the safety and efficacy of drug candidates. We offer broad experience in molecular/genomic testing, vaccine safety assessment, immunogenicity, and cell-based assays.
IntoDNA is a service provider that delivers its technology STRIDE for super-sensitive, direct, in situ DNA damage detection combined with a set of comprehensive solutions and expertise to support customers and projects within the area of precision medicine that develops DDR targeted therapies. IntoDNA provides tools that can be applied in cells and tissue samples.
Learn more about how you can enrich your research and drug development process with precise DNA damage analysis:
BPS Bioscience’s purpose is to advance new scientific discoveries that lead to therapies by creating innovative solutions for research. Our focus areas are immunotherapy, epigenetics, coronavirus, CRISPR, cell signaling, and others, providing 4500+ high quality recombinant cell lines, lentiviruses, proteins and biochemical and cell-based assay kits. As a primary manufacturer, we can supply products in large-scale bulk quantities, as well as contract and custom manufacturing. Our biochemical and cell-based screening services are also available to accelerate your research.
Beacon Targeted Therapies
We are a clinical trial and pipeline database solution designed in partnership with pharmaceutical professionals. We track targeted therapies to provide accurate, in-depth, and real-time information in the rapidly evolving drug development landscape. For more information or to request a demo, visit our website: